找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Dose-Finding Designs for Early-Phase Cancer Clinical Trials; A Brief Guidebook to Takashi Daimon,Akihiro Hirakawa,Shigeyuki Matsui Book 201

[復制鏈接]
查看: 9713|回復: 40
樓主
發(fā)表于 2025-3-21 16:35:02 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Dose-Finding Designs for Early-Phase Cancer Clinical Trials
副標題A Brief Guidebook to
編輯Takashi Daimon,Akihiro Hirakawa,Shigeyuki Matsui
視頻videohttp://file.papertrans.cn/283/282679/282679.mp4
概述Serves as an excellent resource in the design and analysis of early phase dose-finding trials.Covers a wide range of various methods for designing early phase dose-finding clinical trials in oncology
叢書名稱SpringerBriefs in Statistics
圖書封面Titlebook: Dose-Finding Designs for Early-Phase Cancer Clinical Trials; A Brief Guidebook to Takashi Daimon,Akihiro Hirakawa,Shigeyuki Matsui Book 201
描述This book provides a comprehensive introduction to statistical methods for designing early phase dose-finding clinical trials. It will serve as a textbook or handbook for graduate students and practitioners in biostatistics and clinical investigators who are involved in designing, conducting, monitoring, and analyzing dose-finding trials. The book will also provide an overview of advanced topics and discussions in this field for the benefit of researchers in biostatistics and statistical science. Beginning with backgrounds and fundamental notions on dose finding in early phase clinical trials, the book then provides traditional and recent dose-finding designs of phase I trials for, e.g., cytotoxic agents in oncology, to evaluate toxicity outcome. Included are rule-based and model-based designs, such as 3 + 3 designs, accelerated titration designs, toxicity probability interval designs, continual reassessment method and related designs, and escalation overdose control designs. This bookalso covers more complex and updated dose-finding designs of phase I-II and I/II trials for cytotoxic agents, and cytostatic agents, focusing on both toxicity and efficacy outcomes, such as designs wi
出版日期Book 2019
關(guān)鍵詞Adaptive Design; Cancer; Dose Finding; Phase I; Phase I/II
版次1
doihttps://doi.org/10.1007/978-4-431-55585-8
isbn_softcover978-4-431-55584-1
isbn_ebook978-4-431-55585-8Series ISSN 2191-544X Series E-ISSN 2191-5458
issn_series 2191-544X
copyrightThe Author(s), under exclusive licence to Springer Japan KK 2019
The information of publication is updating

書目名稱Dose-Finding Designs for Early-Phase Cancer Clinical Trials影響因子(影響力)




書目名稱Dose-Finding Designs for Early-Phase Cancer Clinical Trials影響因子(影響力)學科排名




書目名稱Dose-Finding Designs for Early-Phase Cancer Clinical Trials網(wǎng)絡(luò)公開度




書目名稱Dose-Finding Designs for Early-Phase Cancer Clinical Trials網(wǎng)絡(luò)公開度學科排名




書目名稱Dose-Finding Designs for Early-Phase Cancer Clinical Trials被引頻次




書目名稱Dose-Finding Designs for Early-Phase Cancer Clinical Trials被引頻次學科排名




書目名稱Dose-Finding Designs for Early-Phase Cancer Clinical Trials年度引用




書目名稱Dose-Finding Designs for Early-Phase Cancer Clinical Trials年度引用學科排名




書目名稱Dose-Finding Designs for Early-Phase Cancer Clinical Trials讀者反饋




書目名稱Dose-Finding Designs for Early-Phase Cancer Clinical Trials讀者反饋學科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 23:29:49 | 只看該作者
Model-Based Designs Considering Toxicity Alone,oses, and originate from the continual reassessment method (CRM). The present chapter provides a detailed description of the concepts, theories, properties, and advantages and disadvantages of the CRM, and also overview designs that are related to the CRM or that constitute extended versions of this method.
板凳
發(fā)表于 2025-3-22 03:18:04 | 只看該作者
Model-Assisted Designs Considering Toxicity Alone, before trial initiation. The model-assisted designs considering toxicity alone include, e.g., the modified toxicity probability interval (mTPI) design and its improved design (the mTPI-2 design), Bayesian optimal interval design, and keyboard design. In this chapter, we overview these designs and discuss related topics.
地板
發(fā)表于 2025-3-22 08:00:12 | 只看該作者
Designs for Early-Phase Immunotherapeutic Agent Trials,ical to successful treatment. Such doses are found by considering the outcome related to the immune response in addition to the toxicity and efficacy outcomes. This chapter reviews several dose-finding designs for early-phase immunotherapy trials.
5#
發(fā)表于 2025-3-22 11:36:25 | 只看該作者
6#
發(fā)表于 2025-3-22 15:45:45 | 只看該作者
7#
發(fā)表于 2025-3-22 19:22:38 | 只看該作者
8#
發(fā)表于 2025-3-22 21:16:07 | 只看該作者
Book 2019book or handbook for graduate students and practitioners in biostatistics and clinical investigators who are involved in designing, conducting, monitoring, and analyzing dose-finding trials. The book will also provide an overview of advanced topics and discussions in this field for the benefit of re
9#
發(fā)表于 2025-3-23 03:10:54 | 只看該作者
10#
發(fā)表于 2025-3-23 06:48:09 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-27 02:51
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
灵台县| 新野县| 吉安市| 昌图县| 清丰县| 金溪县| 夏津县| 如皋市| 大理市| 临漳县| 教育| 湘潭市| 太原市| 上林县| 三明市| 绿春县| 长武县| 孝义市| 上高县| 济南市| 盐源县| 澜沧| 包头市| 淮南市| 即墨市| 郑州市| 喜德县| 景洪市| 凤庆县| 五寨县| 无为县| 年辖:市辖区| 云安县| 迭部县| 波密县| 商都县| 佛教| 藁城市| 枣强县| 滦平县| 长春市|